abagovomab
paratope
ravulizumab
solitomab
vanucizumab
olaratumab
brolucizumab
complement
immunochemistry
immunoproteomics
idiospecific
immunoaffinity
crossreaction
heteroclitic antibody
antisynthetase
immunoantigen
horseradish peroxidase
immunospecific
seroimmunity
immunosorbent
target cell
radioimmunoprecipitate
bivatuzumab
despeciation
intetumumab
radioimmunoreactivity
talizumab
heterophile
antisubstance
soravtansine
presentation
monospecific
cibisatamab
active immunity
radioimmunoelectrophoresis
immunoprobe
clenoliximab
amlitelimab
-mab
immunocytic
monoantibody
xenoantibody
countercorrelated
antimonoclonal
immunoadsorbent
glembatumumab
antihuman